SL Therapeutics, Inc. (XKON: 258540)
South Korea flag South Korea · Delayed Price · Currency is KRW
839.00
-61.00 (-6.78%)
Dec 24, 2024, 9:00 AM KST

SL Therapeutics Company Description

SL Therapeutics, Inc. engages in cell therapy and medical device businesses.

The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system.

It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices.

The company was formerly known as StemLab Inc. SL Therapeutics, Inc. was founded in 2011 and is headquartered in Seoul, South Korea.

SL Therapeutics, Inc.
Country South Korea
Founded 2011
Industry Commercial Physical and Biological Research
CEO Jong Sung Choi

Contact Details

Address:
711, Techno Complex of Korea University
Seoul, 02841
South Korea
Phone 82 2 2070 1177
Website stemlab.co.kr

Stock Details

Ticker Symbol 258540
Exchange Korea New Exchange
Reporting Currency KRW
SIC Code 8731

Key Executives

Name Position
Jong Sung Choi Chief Executive Officer